Business Daily.
.
A+ R A-

Engineered TCR and CAR Immunotherapeutics 2015 is a new market research publication announced by Reportstack. The engineered T cell receptor (TCR) for targeting of intracellular targets not druggable by conventional antibody technologies, and specifically targeted engineered T cells are two of the most promising emerging technologies in...

More Articles...

Page 8580 of 11582

Business Daily Media